Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study

OBJECTIVES: Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Umifenovir (Arbidol®) is an antiviral drug being used to treat influenza in Russia and China. This study aimed to investigate the effectiveness and safety of umifenovir for...

Descripción completa

Detalles Bibliográficos
Autores principales: Lian, N., Xie, H., Lin, S., Huang, J., Zhao, J., Lin, Q.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182750/
https://www.ncbi.nlm.nih.gov/pubmed/32344167
http://dx.doi.org/10.1016/j.cmi.2020.04.026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182750/
https://www.ncbi.nlm.nih.gov/pubmed/32344167
http://dx.doi.org/10.1016/j.cmi.2020.04.026

Ejemplares similares